Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone, and thank you for joining us here today. It is my pleasure to introduce Mike Rossi, President and CEO of Y-mAbs, who will be leading the presentation today; and Bo Kruse, CFO, will be joining Mike in the Q&A.
With that, I'll hand it over to Mike. Thank you, Mike, for joining us here today and sharing your story with us.
Thank you very much, and welcome to everyone. Thank you very much for attending our presentation of Y-mAbs Technologies -- Y-mAbs Therapeutics, excuse me. My name is Mike Rossi originally joined in November as the President of CEO. So I'm looking forward to taking you through our novel pre-targeted radiopharmaceutical platform, as well as our antibody-based therapy, DANYELZA. So thank you for attending.
As a disclaimer, please note that any of the forward-looking statements may be made today during our presentation and our disclaimer is available on our Investor Relations website.
So Y
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |